HIGHLIGHTS
- who: Fiorenza Stagni1 and Renata Bartesaghi2* from the Department for Life Quality Studies, University of Bologna, Rimini, Italy, Department of Biomedical and Neuromotor have published the article: The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives, in the Journal: (JOURNAL)
- what: Nonetheless, most of the investigations carried out so far have focused on those triplicated genes on Chr21 (and related pathways) that are thought to be important for the proliferation and fate of NPCs. Considering the milestones of mice brain development, the authors report here only studies in which mice . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.